skip to Main Content
IRBM Is Attending Asia TIDES: Oligonucleotides And Peptide Therapeutics 2019


February 26-28, Tokyo, Japan.
If you are attending AsiaTides from February 26 to February 28, take the opportunity to meet with Heidi Kingdon-Jones and Dr. Raffaele Ingenito, and learn more about how IRBM can support your drug discovery program.
IRBM Is Attending The BIO Asia International Conference 2019

BIO Asia

March 4-6, Tokyo, Japan
Meet Heidi Kingdon-Jones, our Global VP of Sales and Marketing, at BioAsia from March 4 to March 6! To learn more about how IRBM’s capabilities and how we can support and accelerate your drug discovery programs.
IRBM Is Attending The 32nd International Conference On Vaccines And Immunization

32nd Vaccines and Immunization Conference

Pier Giorgio Pacifici, Ph.D., IRBM’s Business Development Manager, and Stefania Di Marco, PhD, QP at IRBM’s GMP-compliant adenoviral-based vaccine manufacturing facility ADVENT, will be attending the International Conference on Vaccines and Immunization in Rome on March 21st-22nd. The event unites…

5th European Bioanalysis Forum YYS March 21-22 Bologna, Italy

5th European Bioanalysis Forum YYS

On March 21-22, Simone Esposito (Research Scientist) will be attending 5th European Bioanalysis Forum YYS in Bologna, Italy. To learn more about how IRBM can support your drug discovery, drop us a line to request a meeting!

IRBM Is Attending The AACR Annual Meeting 2019

AACR Annual Meeting 2019

The American Association for Cancer Research Annual Meeting is being held from March 29th to April 3rd in Atlanta, Georgia. The event highlights the transformative work being undertaken across the broad spectrum of cancer research from organizations worldwide. Carlo Toniatti,…

IRBM -European IN Cell User Meeting

European IN Cell User Meeting

Our Director of High Throughput Biology and Screening, Alberto Bresciani, will be attending the European IN Cell User Meeting from April 8th-9th in Mannheim, Germany. The two-day event features an interesting range of talks, and is organized by GE Healthcare.…

IRBM Is Attending The EASL International Liver Congress 2019

EASL 2019

We will be the EASL International Liver Congress from April 10th to 14th in Vienna. The annual event welcomes leading scientific and medical experts to explore cutting-edge developments in fields allied to hepatology. Vincenzo Summa, VP of Drug Development, and…

IRBM Is Attending The World Vaccine Congress 2019

World Vaccine Congress

We're gearing up for the World Vaccine Congress, which is being held in Washington D.C. from April 14th to 17th. Having run for nearly two decades, the conference demonstrates how innovative research can be integrated into Pharma, academia and policy,…


BioTrinity 2019

Our Global VP of Sales and Marketing, Heidi Kingdon Jones, is attending BioTrinity Europe in London from April 30th to May 1st. Now in its 13th year, BioTrinity is Europe's leading biopartnering and investment conference. Get in touch to organize…

IRBM Is Attending Swiss Biotech Day 2019

Swiss Biotech Day 2019

On May 7th, Pier Giorgio Pacifici, our Business Development Manager, will be in Basel attending Swiss Biotech Day 2019. The event brings together leading biotechnological and pharmaceutical researchers, analysts, stakeholders, decision makers and more to discuss their innovations within these…

IRBM Will Be Attending Will Be Attending MIXiii-Biomed In Tel Aviv, Israel.


From May 14th-16th, Matteo Liguori, Managing Director, and Heidi Kingdon Jones, Global VP of Sales and Marketing, will be in Tel Aviv for MIXiii-Biomed. The event is billed as the main healthcare meeting in Israel, attracting key stakeholders from around the world to explore…



Dan Conlon, VP of Business Development, and Stefania Colarusso, Senior Research Investigator, will be attending the USA TIDES: Oligonucleotides and Peptide Therapeutics event next week. As part of the conference's agenda, Stefania will be delivering a talk entitled: "An appropriate…

Back To Top